444 results on '"Tadayuki Oshima"'
Search Results
2. How should we interpret the data of eosinophilic esophagitis patients from an academic institution?
- Author
-
Tadayuki Oshima
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Published
- 2023
- Full Text
- View/download PDF
3. A minute primary gastric synovial sarcoma with ulcer: a case report
- Author
-
Kanako Yoshiyasu, Hiroshi Kono, Yudai Hojo, Yoshinori Ishida, Akio Tamura, Keisuke Nakai, Tadayuki Oshima, Hiroto Miwa, Hisashi Shinohara, and Seiichi Hirota
- Subjects
Synovial sarcoma ,Monophasic fibrous type ,Stomach ,Fusion gene analysis ,SS18-SSX1 ,Pathology ,RB1-214 - Abstract
Abstract Background Synovial sarcomas are a rare type of high-grade sarcomas with unknown cell origin. They arise predominantly in the soft tissues but rarely in the stomach. We recently encountered a rare case of minute gastric synovial sarcoma. Case presentation A 61-year-old Japanese woman was pointed out edematous erosion at the body of the stomach. Biopsy specimen showed dense proliferation of spindle-shaped tumor cells mixed with smooth muscle fibers of the muscularis mucosae. Although the definite histological diagnosis was undetermined, the patient underwent laparoscopic wedge resection of the stomach. Histological examination of the resected sample revealed that the maximum diameter of the tumor was only 6 mm and that dense proliferation of rather uniform spindle tumor cells were observed mainly in the submucosa. Immunohistochemistry showed that they were positive for pan-keratin, CD99 and TLE1. SS18-SSX fusion-specific antibody gave diffuse positive staining to the tumor cells, and analysis using mRNA extracted from paraffin sections revealed that the tumor had SS18-SSX1 fusion gene. Thus, it was diagnosed as gastric synovial sarcoma, monophasic fibrous type. Conclusions Primary synovial sarcoma of the stomach is rare and only 47 cases have been reported in the English literature to date. The maximum diameter of the lesion of our case was 6 mm which is the smallest among them.
- Published
- 2021
- Full Text
- View/download PDF
4. Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin
- Author
-
Jiro Watari, Toshihiko Tomita, Katsuyuki Tozawa, Tadayuki Oshima, Hirokazu Fukui, and Hiroto Miwa
- Subjects
helicobacter pylori ,stomach neoplasms ,eradication ,aspirin ,pathology ,molecular ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Whether Helicobacter pylori eradication actually reduces the risk of metachronous gastric cancer (MGC) development remains a controversial question. In this review, we addressed this topic by reviewing the results of clinical investigations and molecular pathological analyses of the roles of H. pylori eradication and aspirin administration in the prevention of MGC. In regard to the clinical studies, the results of meta-analyses and randomized control trials differ from those of retrospective studies: the former trials show that H. pylori eradication has a preventive effect on MGC, while the latter studies do not. This discrepancy may be at least partly attributable to differences in the follow-up periods: H. pylori eradication is more likely to prevent MGC over a long-term follow-up period (≥5 years) than over a short-term follow-up period. In addition, many studies have shown that aspirin may have an additive effect on MGC-risk reduction after H. pylori eradication has been achieved. Both H. pylori eradication and aspirin use induce molecular alterations in the atrophic gastritis mucosa but not in the intestinal metaplasia. Unfortunately, the molecular pathological analyses of these interventions have been limited by short follow-up periods. Therefore, a long-term prospective cohort is needed to clarify the changes in molecular events caused by these interventions.
- Published
- 2020
- Full Text
- View/download PDF
5. Factors associated with high compliance behaviour against COVID-19 in the early phase of pandemic: a cross-sectional study in 12 Asian countries
- Author
-
M Masudur Rahman, Hiroto Miwa, Yinglian Xiao, Yeong Yeh Lee, Tadayuki Oshima, Chun En Chua, Guan Sen Kew, Scott Wong, Hui Xing Lau, Tze Liang Loh, Shien Lung Ooi, Uday C Ghoshal, Ari F Syam, Niandi Tan, Jin-Song Liu, Fang Lu, Chien-Lin Chen, Ruter M Maralit, Yong-Sung Kim, Kewin Tien Ho Siah, Hao Gui, Junxiong Pang, Alla Demutska, Sabrina Quek, Evelyn Xiu Ling Loo, En Xian Sarah Low, Emily C W Hung, Hei Wong, and Cynthia K Y Cheung
- Subjects
Medicine - Abstract
Introduction Regardless of having effective vaccines against COVID-19, containment measures such as enhanced physical distancing and good practice of personal hygiene remain the mainstay of controlling the COVID-19 pandemic. Countries across Asia have imposed these containment measures to varying extents. However, residents in different countries would have a differing degree of compliance to these containment measures potentially due to differences in the level of awareness and motivation in the early phase of pandemic.Objectives In our study, we aimed to describe and correlate the level of knowledge and attitude with the level of compliance with personal hygiene and physical distancing practices among Asian countries in the early phase of pandemic.Methods A multinational cross-sectional study was carried out using electronic surveys between May and June 2020 across 14 geographical areas. Subjects aged 21 years and above were invited to participate through social media, word of mouth and electronic mail.Results Among the 2574 responses obtained, 762 (29.6%) participants were from East Asia and 1812 (70.4%) were from Southeast Asia (SEA). A greater proportion of participants from SEA will practise physical distancing as long as it takes (72.8% vs 60.6%). Having safe distancing practices such as standing more than 1 or 2 m apart (AdjOR 5.09 95% CI (1.08 to 24.01)) or more than 3 or 4 m apart (AdjOR 7.05 95% CI (1.32 to 37.67)), wearing a mask when they had influenza-like symptoms before the COVID-19 pandemic, preferring online news channels such as online news websites/applications (AdjOR 1.73 95% CI (1.21 to 2.49)) and social media (AdjOR 1.68 95% CI (1.13 to 2.50) as sources of obtaining information about COVID-19 and high psychological well-being (AdjOR 1.39 95% CI (1.04 to 1.87)) were independent factors associated with high compliance.Conclusions We found factors associated with high compliance behaviour against COVID-19 in the early phase of pandemic and it will be useful to consider them in risk assessment, communication and pandemic preparedness.
- Published
- 2021
- Full Text
- View/download PDF
6. Association between well-being and compliance with COVID-19 preventive measures by healthcare professionals: A cross-sectional study.
- Author
-
Shimoni Urvish Shah, Evelyn Xiu Ling Loo, Chun En Chua, Guan Sen Kew, Alla Demutska, Sabrina Quek, Scott Wong, Hui Xing Lau, En Xian Sarah Low, Tze Liang Loh, Ooi Shien Lung, Emily C W Hung, M Masudur Rahman, Uday C Ghoshal, Sunny H Wong, Cynthia K Y Cheung, Ari F Syam, Niandi Tan, Yinglian Xiao, Jin-Song Liu, Fang Lu, Chien-Lin Chen, Yeong Yeh Lee, Ruter M Maralit, Yong-Sung Kim, Tadayuki Oshima, Hiroto Miwa, Kewin Tien Ho Siah, and Junxiong Pang
- Subjects
Medicine ,Science - Abstract
ImportanceKnowledge and attitude influence compliance and individuals' practices. The risk and protective factors associated with high compliance to these preventive measures are critical to enhancing pandemic preparedness.ObjectiveThis survey aims to assess differences in mental health, knowledge, attitudes, and practices (KAP) of preventive measures for COVID-19 amongst healthcare professionals (HCP) and non-healthcare professionals.DesignMulti-national cross-sectional study was carried out using electronic surveys between May-June 2020.SettingMulti-national survey was distributed across 36 countries through social media, word-of-mouth, and electronic mail.ParticipantsParticipants ≥21 years working in healthcare and non-healthcare related professions.Main outcomeRisk factors determining the difference in KAP towards personal hygiene and social distancing measures during COVID-19 amongst HCP and non-HCP.ResultsHCP were significantly more knowledgeable on personal hygiene (AdjOR 1.45, 95% CI -1.14 to 1.83) and social distancing (AdjOR 1.31, 95% CI -1.06 to 1.61) compared to non-HCP. They were more likely to have a positive attitude towards personal hygiene and 1.5 times more willing to participate in the contact tracing app. There was high compliance towards personal hygiene and social distancing measures amongst HCP. HCP with high compliance were 1.8 times more likely to flourish and more likely to have a high sense of emotional (AdjOR 1.94, 95% CI (1.44 to 2.61), social (AdjOR 2.07, 95% CI -1.55 to 2.78), and psychological (AdjOR 2.13, 95% CI (1.59-2.85) well-being.Conclusion and relevanceWhile healthcare professionals were more knowledgeable, had more positive attitudes, their higher sense of total well-being was seen to be more critical to enhance compliance. Therefore, focusing on the well-being of the general population would help to enhance their compliance towards the preventive measures for COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
7. Decreased Colonic Guanylin/Uroguanylin Expression and Dried Stool Property in Mice With Social Defeat Stress
- Author
-
Nobuhiko Ebisutani, Hirokazu Fukui, Heihachiro Nishimura, Takashi Nakanishi, Kenki Morimoto, Shiho Itou, Ayumi Nakamura, Mizuki Masutani, Mika Hori, Toshihiko Tomita, Tadayuki Oshima, Emiko Kasahara, Atsuo Sekiyama, and Hiroto Miwa
- Subjects
social defeat stress ,depression ,constipation ,guanylin ,uroguanylin ,guanylate cyclase 2C ,Physiology ,QP1-981 - Abstract
Psychological stress is deeply involved in the pathophysiology of not only mental illness but also functional gastrointestinal disorders. In the present study, we examined the relationship between psychological stress and abnormality of stool properties, focusing on the alteration of plasma glucocorticoid and guanylin (GN)/uroguanylin (UGN) expression in the colon. A murine model of chronic social defeat stress (CSDS) was established by exposing a C57BL/6N intruder mouse to a CD-1 aggressor mouse for 3–5 min. Thereafter the mice were kept in the same cage but separated by a divider for the remainder of the day. This procedure was repeated for 10 consecutive days, and then a social interaction test was performed to evaluate social avoidance. Fresh fecal and blood samples were collected for stool property analysis and measurement of the plasma glucocorticoid level by ELISA. The expression of GN, UGN, and guanylate cyclase 2C in the colonic tissues was examined by real-time RT-PCR and immunohistochemistry. Moreover, Lovo cells were stimulated with dexamethasone, and the expression of GN/UGN mRNA was examined. In the CSDS group, the time spent in the social interaction zone was significantly shorter when the CD-1 aggressor mouse was present than when it was absent. The social interaction ratio was also significantly lower in the CSDS group relative to the controls. The mean Bristol scale score was significantly lower in the CSDS group, but the fecal sodium concentration did not differ between CSDS mice and controls. The level of plasma corticosterone was significantly higher in the CSDS group than in the controls immediately after the 10th day of CSDS. The expression of both GN and UGN was significantly decreased in the CSDS mice. GN was expressed in all colonic epithelial cells, and UGN was expressed in ovoid or pyramidal epithelial cells in the colonic mucosa. The expression of both GN and UGN was significantly decreased in the CSDS mice relative to controls. The expression of both GN and UGN was significantly suppressed in Lovo cells upon stimulation with dexamethasone. Psychological stress-induced glucocorticoid may suppress colonic GN/UGN expression, resulting in a change in stool properties leading to constipation.
- Published
- 2020
- Full Text
- View/download PDF
8. Rectal Foreign Body of Eggplant Treated Successfully by Endoscopic Transanal Removal
- Author
-
Hiroo Sei, Toshihiko Tomita, Keisuke Nakai, Kumiko Nakamura, Akio Tamura, Yoshio Ohda, Tadayuki Oshima, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Rectal foreign body ,Eggplant ,Endoscopic treatment ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Transanal rectal foreign body implies that a foreign body has been inserted transanally due to sexual orientation or other reasons and cannot be removed. Such cases require emergency measures because foreign bodies often present difficulties in manual removal or endoscopic removal and may even require surgery when peritonitis due to gastrointestinal perforation occurs. We report a patient in our hospital who had a rectal foreign body inserted into the deep part of the proctosigmoid that could be removed endoscopically. A 66-year-old man visited our hospital because of an eggplant which had been inserted into his rectum by his friend and could not be removed. Since plain abdominal computed tomography showed a foreign body thought to be an eggplant in the proctosigmoid, the foreign body was captured and removed with a snare under lower gastrointestinal endoscope guidance.
- Published
- 2018
- Full Text
- View/download PDF
9. Effect of a High-Fat Diet on the Small-Intestinal Environment and Mucosal Integrity in the Gut-Liver Axis
- Author
-
Takashi Nakanishi, Hirokazu Fukui, Xuan Wang, Shin Nishiumi, Haruka Yokota, Yutaka Makizaki, Yoshiki Tanaka, Hiroshi Ohno, Toshihiko Tomita, Tadayuki Oshima, and Hiroto Miwa
- Subjects
high-fat diet ,small intestine ,microbiome ,bile acid ,barrier ,Cytology ,QH573-671 - Abstract
Although high-fat diet (HFD)-related dysbiosis is involved in the development of steatohepatitis, its pathophysiology especially in the small intestine remains unclear. We comprehensively investigated not only the liver pathology but also the microbiome profile, mucosal integrity and luminal environment in the small intestine of mice with HFD-induced obesity. C57BL/6J mice were fed either a normal diet or an HFD, and their small-intestinal contents were subjected to microbial 16S rDNA analysis. Intestinal mucosal permeability was evaluated by FITC-dextran assay. The levels of bile acids in the small-intestinal contents were measured by liquid chromatography/mass spectrometry. The expression of tight junction molecules, antimicrobial peptides, lipopolysaccharide and macrophage marker F4/80 in the small intestine and/or liver was examined by real-time RT-PCR and immunohistochemistry. The abundance of Lactobacillus was markedly increased and that of Clostridium was drastically decreased in the small intestine of mice fed the HFD. The level of conjugated taurocholic acid was significantly increased and those of deconjugated cholic acid/secondary bile acids were conversely decreased in the small-intestinal contents. The expression of occludin, antimicrobial Reg IIIβ/γ and IL-22 was significantly decreased in the small intestine of HFD-fed mice, and the intestinal permeability was significantly accelerated. Infiltration of lipopolysaccharide was significantly increased in not only the small-intestinal mucosa but also the liver of HFD-fed mice, and fat drops were apparently accumulated in the liver. Pathophysiological alteration of the luminal environment in the small intestine resulting from a HFD is closely associated with minimal inflammation involving the gut-liver axis through disturbance of small-intestinal mucosal integrity.
- Published
- 2021
- Full Text
- View/download PDF
10. Author Correction: Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats
- Author
-
Hirokazu Fukui, Tadayuki Oshima, Yoshiki Tanaka, Yosuke Oikawa, Yutaka Makizaki, Hiroshi Ohno, Toshihiko Tomita, Jiro Watari, and Hiroto Miwa
- Subjects
Medicine ,Science - Published
- 2021
- Full Text
- View/download PDF
11. The Link between Type III Reg and STAT3-Associated Cytokines in Inflamed Colonic Tissues
- Author
-
Xin Xu, Hirokazu Fukui, Ying Ran, Xuan Wang, Yoshihito Inoue, Nobuhiko Ebisudani, Heihachiro Nishimura, Toshihiko Tomita, Tadayuki Oshima, Jiro Watari, Hiroshi Kiyama, and Hiroto Miwa
- Subjects
Pathology ,RB1-214 - Abstract
Reg (regenerating gene) family proteins are known to be overexpressed in gastrointestinal (GI) tissues under conditions of inflammation. However, the pathophysiological significance of Reg family protein overexpression and its regulation is still unclear. In the present study, we investigated the profile of Reg family gene expression in a colitis model and focused on the regulation of Reg IIIβ and IIIγ, which are overexpressed in inflamed colonic mucosa. C57BL/6 mice were administered 2% dextran sulfate sodium (DSS) in drinking water for five days, and their colonic tissues were investigated histopathologically at interval for up to 12 weeks. Gene expression of the Reg family and cytokines (IL-6, IL-17, and IL-22) was evaluated by real-time RT-PCR, and Reg IIIβ/γ expression was examined by immunohistochemistry. The effects of cytokines on STAT3 phosphorylation and HIP/PAP (type III REG) expression in Caco2 and HCT116 cells were examined by Western blot analysis. Among Reg family genes, Reg IIIβ and IIIγ were alternatively overexpressed in the colonic tissues of mice with DSS-induced colitis. The expression of STAT3-associated cytokines (IL-6, IL-17, and IL-22) was also significantly increased in those tissues, being significantly correlated with that of Reg IIIβ/γ. STAT3 phosphorylation and HIP/PAP expression were significantly enhanced in Caco2 cells upon stimulation with IL-6, IL-17, and IL-22. In HCT116 cells, those enhancements were also observed by IL-6 and IL-22 stimulations but not IL-17. The link between type III Reg and STAT3-associated cytokines appears to play a pivotal role in the pathophysiology of DSS-induced colitis.
- Published
- 2019
- Full Text
- View/download PDF
12. Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats
- Author
-
Xuan Wang, Hirokazu Fukui, Ying Ran, Xin Xu, Nobuhiko Ebisutani, Takashi Nakanishi, Yoshiki Tanaka, Ayako Maeda, Yutaka Makizaki, Toshihiko Tomita, Tadayuki Oshima, and Hiroto Miwa
- Subjects
Bifidobacterium ,maternal separation ,permeability ,macrophage ,cytokines ,tight junction ,Biology (General) ,QH301-705.5 - Abstract
Although probiotics may be useful for the treatment of irritable bowel syndrome (IBS), it is unclear how probiotics play a role in colonic mucosal integrity and immunity. Here, we aimed to investigate the effect of Bifidobacterium bifidum G9-1 (BBG9-1) on colonic mucosal integrity and macrophage behavior in rats subjected to maternal separation (MS) as a model of IBS. MS pups were individually separated from their mother rats, and a proportion of the MS rats were orally administered BBG9-1. The colonic mucosal permeability was evaluated by Ussing chamber assay. The expression of tight junction proteins and cytokines and the population of CD80-positive cells was examined in the colonic tissues by real-time reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry. Caco2 cells were stimulated with cytokines and the transepithelial electric resistance (TEER) was measured. MS rats showed significantly higher colonic permeability and lower claudin 4 expression in the colonic epithelium relative to controls. The number of CD80-positive macrophages was significantly increased in the colonic mucosa of MS rats, accompanied by the increase of IL-6 and IFN-γ expression. BBG9-1 treatment ameliorated the increase of M1 macrophage and IL-6/IFN-γ expression in the colonic tissue of MS rats. Simultaneously, BBG9-1 treatment improved the enhanced mucosal permeability and the decreased claudin 4 expression in the colon of MS rats. IL-6 and IFN-γ, whose expression is enhanced in the colon of MS rats, significantly decreased TEER in Caco2 cells in vitro. Probiotic BBG9-1 has a preventive effect on the acceleration of colonic permeability and M1 macrophage population in maternally separated rats.
- Published
- 2021
- Full Text
- View/download PDF
13. Role of the β-Catenin/REG Iα Axis in the Proliferation of Sessile Serrated Adenoma/Polyps Associated with Fusobacterium nucleatum
- Author
-
Heihachiro Nishimura, Hirokazu Fukui, Xuan Wang, Nobuhiko Ebisutani, Takashi Nakanishi, Toshihiko Tomita, Tadayuki Oshima, Seiichi Hirota, and Hiroto Miwa
- Subjects
Fusobacterium nucleatum ,sessile serrated adenoma ,polyp ,β-catenin ,REG ,Ki67 ,Medicine - Abstract
Although sessile serrated adenoma/polyps (SSA/Ps) may arise through a pathway different from the traditional adenoma–carcinoma sequence, details of SSA/P tumorigenesis still remain unclear. Fusobacterium nucleatum (Fn) is frequently detected in colorectal cancer (CRC) tissues and may play a pivotal role in colorectal carcinogenesis. Here, we investigated the relationship between Fn and the β-catenin/REG Iα axis in SSA/Ps and their involvement in the proliferation of these lesions. Fn was detected in SSA/Ps by fluorescence in situ hybridization using a Fn-targeted probe, and expression of β-catenin, REG Iα and Ki67 was examined using immunohistochemistry. Sixteen of 30 SSA/P lesions (53.3%) were positive for Fn. Eighteen SSA/P lesions (60%) showed β-catenin immunoreactivity in the tumor cell nuclei. A significant majority of Fn-positive lesions showed nuclear expression of β-catenin (87.5%) and higher REG Iα scores and Ki67 labeling indices relative to Fn-negative lesions. The SSA/P lesions expressing β-catenin in nuclei had significantly higher REG Iα scores and Ki67 labeling indices than those expressing β-catenin on cytomembranes. The REG Iα score was positively correlated with the Ki67 labeling index in SSA/P lesions. The treatment with Wnt agonist SKL2001 promoted nuclear β-catenin translocation and enhanced REG Ia expression in Caco2 cells. Fn may play a role in the proliferation of SSA/P lesions through promotion of β-catenin nuclear translocation and REG Iα expression.
- Published
- 2021
- Full Text
- View/download PDF
14. Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels
- Author
-
Xinyi Huang, Tadayuki Oshima, Toshihiko Tomita, Hirokazu Fukui, and Hiroto Miwa
- Subjects
short-chain fatty acids ,butyrate ,claudin-2 ,intestinal barrier disruption ,Biology (General) ,QH301-705.5 - Abstract
Gastrointestinal (GI) disorders such as celiac disease and inflammatory bowel disease are attributed to intestinal barrier disruption. Imbalance of cytokines has been reported in the intestinal epithelium of patients with GI disorders. Short-chain fatty acids (SCFAs), derived from the fermentation of dietary fiber in the intestine, have been reported to benefit the intestinal barrier. Accordingly, we evaluated the effect of specific SCFAs on intestinal barrier function under cytokine-stimulated conditions. Caco-2 cells were cultured on insert membranes to generate monolayers, which then were used to investigate the effects of SCFAs. Tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), or interleukin-13 (IL-13) was added to the basolateral side of the membrane while SCFAs were added to the apical side. After a 24 h stimulation, transepithelial electrical resistance (TEER) was measured, and the protein levels of claudin-1, claudin-2, claudin-3, claudin-4, occludin, and zonula occludens-1 (ZO-1) were evaluated by Western blot. Butyrate, but not acetate, propionate, or succinate, ameliorated the TNF-α/IFN-γ-induced decrease in TEER. TNF-α/IFN-γ stimulation significantly increased the protein level of claudin-2 and decreased the level of claudin-3. Butyrate significantly attenuated the upregulation of claudin-2 induced by TNF-α/IFN-γ. Butyrate blocked the decrease in TEER and the upregulation of claudin-2 induced by IL-13 without changing the level of other tight junction proteins. Our results suggested that butyrate is the main component of SCFAs to alleviate barrier dysfunction and that claudin-2 is the major target of this SCFA.
- Published
- 2021
- Full Text
- View/download PDF
15. Objective image analysis of non-magnifying image-enhanced endoscopy for diagnosis of small depressed early gastric cancers
- Author
-
Jiro Watari, Masaya Kobayashi, Keisuke Nakai, Chiyomi Ito, Akio Tamura, Tomohiro Ogawa, Takahisa Yamasaki, Takuya Okugawa, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Takeshi Morimoto, and Hiroto Miwa
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background Gastric cancers (GC) after H. pylori eradication are difficult to diagnose even by magnifying narrow-band imaging (NBI) or blue laser imaging (BLI) endoscopy. Little is known with regard to non-magnifying (NM)-NBI/BLI for early GC so we examined the efficacy of NM-NBI/BLI for early GC diagnosis. Methods We retrospectively analyzed the images of 29 small (≤ 1 cm) intramucosal GC that had been treated with endoscopic submucosal dissection and 137 benign depressed lesions (BDLs). The brightness and shape of the GCs and BDLs by NM-NBI/BLI were assessed with ImageJ software. Results The NBI/BLI-index, which indicates the brightness of NBI/BLI for visualization, was significantly higher in GC than BDLs in both the H. pylori-infected (P = 0.009) and -eradicated group (P
- Published
- 2018
- Full Text
- View/download PDF
16. Are the Symptoms of an NSAID-Induced Ulcer Truly Milder Than Those of an Ordinary Ulcer?
- Author
-
Toshihiko Tomita, Sumire Mori, Katsuyuki Tozawa, Eitatsu Arai, Nobuo Tano, Hideo Oka, Yongmin Kim, Takashi Abe, Yoshio Ohda, Tadayuki Oshima, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Objective. The percentage of patients with nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin- (LDA-) induced ulcers who complain of gastrointestinal symptoms has generally been considered to be low. The aim of this study was to examine and compare the symptoms and quality of life (QOL) at peptic ulcer onset. Methods. This study involved 200 patients who were confirmed by endoscopy to be in the acute stage of gastroduodenal ulcer (A1-H1). Patients completed a self-administered questionnaire (Global Overall Symptom score and SF-8) at ulcer onset, and data were compared between NSAIDs/LDA ulcers and non-NSAIDs/LDA ulcers. Results. The upper gastrointestinal symptoms score was significantly lower for patients using LDA only (20.5 ± 9.4 in the nonusing group, 19.6 ± 8.6 in the NSAIDs-only group, 16.7 ± 11.6 in the LDA-only group, and 18.5 ± 7.2 in the NSAIDs/LDA group, P
- Published
- 2017
- Full Text
- View/download PDF
17. Effect of Helicobacter pylori infection on the link between GLP-1 expression and motility of the gastrointestinal tract.
- Author
-
Hirotsugu Eda, Hirokazu Fukui, Ryosuke Uchiyama, Yoshitaka Kitayama, Ken Hara, Mo Yang, Mio Kodani, Toshihiko Tomita, Tadayuki Oshima, Jiro Watari, Hiroko Tsutsui, and Hiroto Miwa
- Subjects
Medicine ,Science - Abstract
Although Helicobacter pylori (H. pylori) infection is closely associated with the development of peptic ulcer, its involvement in pathophysiology in the lower intestinal tract and gastrointestinal (GI) motility remains unclear. Glucagon-like peptide-1 (GLP-1) is a gut hormone produced in the lower intestinal tract and involved in GI motility. Here, we investigated the effect of H. pylori infection on the link between GLP-1 expression and motility of the GI tract.C57BL/6 mice were inoculated with a H. pylori strain. Twelve weeks later, the H. pylori-infected mice underwent H. pylori eradication treatment. GI tissues were obtained from the mice at various time intervals, and evaluated for the severity of gastric inflammatory cell infiltration and immunohistochemical expression of GLP-1 and PAX6 in the colonic mucosa. Gastrointestinal transit time (GITT) was measured by administration of carmine-red solution.GLP-1 was expressed in the endocrine cells of the colonic mucosa, and PAX6 immunoreactivity was co-localized in such cells. The numbers of GLP-1- and PAX6-positive cells in the colon were significantly increased at 12 weeks after H. pylori infection and showed a positive correlation with each other. The GITT was significantly longer in H. pylori-infected mice than in non-infected controls and showed a positive correlation with GLP-1 expression. When H. pylori-infected mice underwent H. pylori eradication, GITT and PAX6/GLP-1 expression did not differ significantly from those in untreated H. pylori-infected mice.H. pylori infection may impair GI motility by enhancing the colonic GLP-1/PAX6 expression.
- Published
- 2017
- Full Text
- View/download PDF
18. Successful Self-Expandable Metallic Stent Placement for a Case of Distal Rectal Stenosis due to Gastric Cancer Metastasis
- Author
-
Takuya Okugawa, Tadayuki Oshima, Koichi Ikeo, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Rectal stent ,Gastric cancer ,Carcinomatosis ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
A 47-year-old woman was diagnosed as having advanced gastric cancer with malignant ascites. Despite chemotherapy, recurrent peritoneal dissemination was seen 1.5 years after operation. A computed tomography scan revealed rectal stenosis due to Schnitzler's metastasis. When the distance from the distal end of the obstruction to the anal verge is less than 5 cm, stent replacement has been said to be contraindicated due to the development of anal pain and foreign body sensation. Although the distance from the distal end of the obstruction to the anal verge was 4 cm in this case, a WallFlex™ colonic stent could be placed. She stayed home, and luminal patency remained until she died 270 days after stent insertion. This report demonstrates that rectal obstruction located less than 5 cm from the anal verge due to Schnitzler's metastasis could be treated by stenting without any symptomatic or technical complications.
- Published
- 2013
- Full Text
- View/download PDF
19. Interferon γ-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines.
- Author
-
Jing Shan, Tadayuki Oshima, Liping Wu, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Medicine ,Science - Abstract
BACKGROUND:Esophageal epithelial cells are an initiating cell type in esophageal inflammation, playing an essential role in the pathogenesis of gastroesophageal reflux disease (GERD). A new tissue-derived cytokine, interleukin-33 (IL-33), has been shown to be upregulated in esophageal epithelial cell nuclei in GERD, taking part in mucosal inflammation. Here, inflammatory cytokines secreted by esophageal epithelial cells, and their regulation by IL-33, were investigated. METHODS:In an in vitro stratified squamous epithelial model, IL-33 expression was examined using quantitative RT-PCR, western blot, ELISA, and immunofluorescence. Epithelial cell secreted inflammatory cytokines were examined using multiplex flow immunoassay. IL-33 was knocked down with small interfering RNA (siRNA) in normal human esophageal epithelial cells (HEECs). Pharmacological inhibitors and signal transducers and activators of transcription 1 (STAT1) siRNA were used to explore the signaling pathways. RESULTS:Interferon (IFN)γ treatment upregulated nuclear IL-33 in HEECs. Furthermore, HEECs can produce various inflammatory cytokines, such as IL-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), regulated on activation normal T-cell expressed and presumably secreted (RANTES), and granulocyte-macrophage colony-stimulating factor (GM-CSF) in response to IFNγ. Nuclear, but not exogenous IL-33, amplified IFN induction of these cytokines. P38 mitogen-activated protein kinase (MAPK) and janus protein tyrosine kinases (JAK)/STAT1 were the common signaling pathways of IFNγ-mediated induction of IL-33 and other cytokines. CONCLUSIONS:Esophageal epithelial cells can actively participate in GERD pathogenesis through the production of various cytokines, and epithelial-derived IL-33 might play a central role in the production of these cytokines.
- Published
- 2016
- Full Text
- View/download PDF
20. Correction: Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn.
- Author
-
Hiroo Sei, Tadayuki Oshima, Jing Shan, Liping Wu, Takahisa Yamasaki, Takuya Okugawa, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Medicine ,Science - Abstract
[This corrects the article DOI: 10.1371/journal.pone.0154234.].
- Published
- 2016
- Full Text
- View/download PDF
21. Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn.
- Author
-
Hiroo Sei, Tadayuki Oshima, Jing Shan, Liping Wu, Takahisa Yamasaki, Takuya Okugawa, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Medicine ,Science - Abstract
Interleukin-33 (IL-33) is a tissue-derived cytokine that is constitutively expressed in epithelial cells of tissues exposed to the environment and plays a role in sensing damage caused by inflammatory diseases. IL-33 acts as both a traditional cytokine and as a chromatin-associated nuclear factor in both innate and adaptive immunity. We recently showed that IL-33 in esophageal mucosa is upregulated in reflux esophagitis. However, IL-33 expression in patients with heartburn without mucosal injury and its relationship with intercellular space (ICS) have never been examined. We therefore examined the expression of cytokines and ICS in patients with heartburn.The expression of IL-33 in the middle and distal esophageal mucosa of patients with heartburn without mucosal break and control samples was examined using real-time RT-PCR and immunofluorescence. The mRNA expression of IL-6, IL-8, MCP-1, and RANTES, and ICS was also analyzed.IL-33 expression and the mean ICS were significantly increased in the mucosa of patients with heartburn compared to that of the control. IL-33 and ICS were not different between the patients who were taking a PPI and those who were not. The upregulated IL-33 expression in the heartburn group was located in the nuclei of the basal cell layer. Although IL-6, IL-8, MCP-1 and RANTES levels were not different between control and patients with heartburn samples, IL-33 mRNA levels were still significantly correlated with IL-6, IL-8, or MCP-1 mRNA levels.Nuclear IL-33 is upregulated in patients with heartburn. Upregulated IL-33 in heartburn patients is related to the symptoms.
- Published
- 2016
- Full Text
- View/download PDF
22. Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.
- Author
-
Tadayuki Oshima, Jing Shan, Takuya Okugawa, Xin Chen, Kazutoshi Hori, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Medicine ,Science - Abstract
BACKGROUND: Claudins are known as tight junction proteins, and their expression pattern in gastric cancer is still controversial. The relationship between the expression patterns of tight junction proteins and tumor proliferation in early gastric cancer is still far from clear. AIMS: To investigate the expression patterns of claudin-18 and Ki-67 in early gastric cancer at the invasive front and surrounding normal gastric mucosa and to investigate the biological function of claudin-18 in the proliferation and invasion of cancer cells. METHODS: Seventy-five early gastric cancer lesions removed via endoscopic mucosal resection or endoscopic submucosal resection were evaluated. All gastric cancer lesions were diagnosed as differentiated adenocarcinoma using the Japanese Classification of Gastric Carcinoma. To assess epithelial proliferation, immunostaining with Ki-67 was performed, and the labeling index was calculated. To assess the expression of epithelial tight junction proteins, immunofluorescent staining of claudin-18 was performed. The immunoreactivity of claudin-18 was graded according to the number of stained cells. Correlation analysis was performed by Spearman's rank correlation coefficient. Transfection of claudin-18 small interfering RNA (siRNA) was accomplished in MKN74, a claudin-18-positive gastric cancer cell line, to investigate the effect of claudin-18 on proliferation and invasion of cancer cells. RESULTS: Claudin-18 was significantly down-regulated in gastric cancer compared to surrounding gastric normal mucosa or intestinal metaplasia. The Ki-67 labeling index of gastric cancer at the invasive front was inversely correlated with the claudin-18 level, but that at the mucosal lesion was not correlated. Claudin-18 knockdown significantly promoted the proliferation of MKN74 compared with control siRNA-transfected cells. MKN74 invasion increased significantly with claudin-18 siRNA transfection compared with control siRNA transfection. CONCLUSIONS: Down-regulation of claudin-18 is associated with the proliferative potential at the invasive front of gastric cancer, suggesting that it has a pivotal role in gastric cancer progression.
- Published
- 2013
- Full Text
- View/download PDF
23. Regulatory T cells Are Increased and Correlate With Mast Cells in Eosinophilic Esophagitis.
- Author
-
Junji Chen, Tadayuki Oshima, Toshihiko Tomita, Hirokazu Fukui, and Shinichiro Shinzaki
- Subjects
- *
REGULATORY T cells , *MAST cells , *EOSINOPHILIC esophagitis , *HEMATOXYLIN & eosin staining , *T cells , *MAST cell tumors , *POLYMERASE chain reaction - Abstract
Background/Aims The incidence of eosinophilic esophagitis (EoE) has been increasing recently. The role of regulatory T cells (Tregs) and correlations with other inflammatory cells in EoE remain unknown. We aim to clarify the role of Tregs and their correlations with inflammatory cells in EoE patients. Methods Biopsies from controls and EoE patients before and after treatments were analyzed. Eosinophil infiltration was evaluated by hematoxylin and eosin staining. Immunohistochemical staining was performed to examine infiltration of T cells, Tregs, and mast cells. Gene expressions of chemokines were evaluated by reverse transcription-quantitative polymerase chain reaction. Results Tregs and mast cells were increased in the esophageal epithelial layers of EoE patients. After treatments, Tregs and mast cells were decreased when histologic remission was achieved. Infiltration of Tregs correlated significantly with numbers of eosinophils and mast cells. Filaggrin mRNA was decreased in patients with EoE before treatment and upregulated after treatment, even when histologic remission was not achieved. Conclusions Tregs were increased in esophageal epithelium of patients with EoE, and correlated with mast cell infiltration. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Non-cardiac Chest Pain in Japan: Prevalence, Impact, and Consultation Behavior - A Population-based Study.
- Author
-
Junji Chen, Tadayuki Oshima, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Shinichiro Shinzaki, and Hiroto Miwa
- Subjects
- *
CHEST pain , *GASTROESOPHAGEAL reflux , *INTERNET surveys , *PHYSICIAN services utilization , *HEALTH behavior , *PHYSICIANS - Abstract
Background/Aims Non-cardiac chest pain (NCCP) is defined as recurring angina-like retrosternal chest pain of non-cardiac origin. Information about the epidemiology of NCCP in Japan is lacking. We aim to determine the prevalence and characteristics of NCCP in the Japanese general population. Methods Two internet-based surveys were conducted among the general population in March 2017. Questions investigated the characteristics of symptoms associated with chest pain and consultation behavior. Quality of life, anxiety, depression, and gastroesophageal reflux disease were analyzed. Results Five percent of the survey respondents reported chest pain. Subjects with chest pain showed higher frequencies of anxiety and depression and lower quality of life. Among subjects with chest pain, approximately 30% had sought medical attention for their symptoms. Among all consulters, 70% were diagnosed with NCCP. Females were less likely to seek consultations for chest pain than males. Further, severity and frequency of chest pain, lower physical health component summary score, and more frequent gastroesophageal reflux disease were associated with consultation behavior. Subjects with NCCP and cardiac chest pain experienced similar impacts on quality of life, anxiety, and depression. Among subjects with NCCP, 82% visited a primary-care physician and 15% were diagnosed with reflux esophagitis. Conclusions The prevalence of chest pain in this sample of a Japanese general population was 5%. Among all subjects with chest pain, less than one-third consulted physicians, approximately 70% of whom were diagnosed with NCCP. Sex and both the severity and frequency of chest pain were associated with consultation behavior. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Evidence-based clinical practice guidelines for functional dyspepsia 2021
- Author
-
Hiroto Miwa, Akihito Nagahara, Akihiro Asakawa, Makoto Arai, Tadayuki Oshima, Kunio Kasugai, Kazuhiro Kamada, Hidekazu Suzuki, Fumio Tanaka, Kazunari Tominaga, Seiji Futagami, Mariko Hojo, Hiroshi Mihara, Kazuhide Higuchi, Motoyasu Kusano, Tomiyasu Arisawa, Mototsugu Kato, Takashi Joh, Satoshi Mochida, Nobuyuki Enomoto, Tooru Shimosegawa, and Kazuhiko Koike
- Subjects
Acetylcholinesterase ,Quality of Life ,Gastroenterology ,Humans ,Dyspepsia ,Endoscopy, Gastrointestinal ,Helicobacter Infections - Abstract
Background Functional dyspepsia (FD) is a disorder that presents with chronic dyspepsia, which is not only very common but also highly affects quality of life of the patients. In Japan, FD became a disease name for national insurance in 2013, and has been gradually recognized, though still not satisfactory. Following the revision policy of Japanese Society of Gastroenterology (JSGE), the first version of FD guideline was revised this time. Method Like previously, the guideline was created by the GRADE (grading of recommendations assessment, development and evaluation) system, but this time, the questions were classified to background questions (BQs, 24 already clarified issues), future research questions (FRQs, 9 issues cannot be addressed with insufficient evidence), and 7 clinical questions that are mainly associated with treatment. Results and Conclusion These revised guidelines have two major features. The first is the new position of endoscopy in the flow of FD diagnosis. While endoscopy was required to all cases for diagnosis of FD, the revised guidelines specify the necessity of endoscopy only in cases where organic disease is suspected. The second feature is that the drug treatment options have been changed to reflect the latest evidence. The first-line treatment includes gastric acid-secretion inhibitors, acetylcholinesterase (AChE) inhibitors (acotiamide, a prokinetic agent), and Japanese herbal medicine (rikkunshito). The second-line treatment includes anxiolytics /antidepressant, prokinetics other than acotiamide (dopamine receptor antagonists, 5-HT4 receptor agonists), and Japanese herbal medicines other than rikkunshito. The patients not responding to these treatment regimens are regarded as refractory FD.
- Published
- 2022
- Full Text
- View/download PDF
26. Acid increases PGE2 in the duodenal mucosa in rats
- Author
-
Hirosato Kanda, Shaoqi Duan, Hiroki Yamanaka, Koichi Noguchi, Masashi Fukushima, Hiroto Miwa, Tadahiro Fujimura, Takashi Kondo, Hiroki Okada, Yi Dai, Yoshihito Fujii, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Takashi Konemura, Tomoaki Kono, and Kimiko Kobayashi
- Subjects
medicine.medical_specialty ,Nutrition and Dietetics ,Endocrinology ,Internal medicine ,Clinical Biochemistry ,medicine ,Medicine (miscellaneous) ,Duodenal mucosa - Published
- 2022
- Full Text
- View/download PDF
27. Biologic Therapies Targeting Eosinophilic Gastrointestinal Diseases
- Author
-
Tadayuki Oshima
- Subjects
Internal Medicine ,General Medicine - Published
- 2023
- Full Text
- View/download PDF
28. Evaluation of QOL in Patients with Dyspeptic Symptoms Who Meet or Do Not Meet Rome IV Criteria
- Author
-
Masatoshi Mieno, Toshihiko Tomita, Sota Aono, Katsuyuki Tozawa, Keisuke Nakai, Takuya Okugawa, Masashi Fukushima, Tadayuki Oshima, Hirokazu Fukui, and Hiroto Miwa
- Subjects
Rome IV criteria ,functional dyspepsia ,subdivision of non-FD ,diagnosis ,Medicine ,General Medicine ,Article - Abstract
Health related quality of life (HR-QOL) of functional dyspepsia (FD) patients is impaired. However, the QOL of such patients has not been fully examined. Accordingly, we examined the QOL of Rome IV defined FD, endoscopic negative dyspeptic patients who do not meet the criteria, (non-FD patients) and healthy subjects, and investigated the factors that influence HR-QOL. This was a multicenter, prospective, observational study. Two hundred thirty-five patients (126 FD, 87 non-FD) and 111 healthy subjects were investigated, and non-FD patients were subdivided into three groups: 17 patients failing to meet only the disease duration criterion (Group A), 53 patients failing to meet only disease frequency criterion (Group B) and 17 patients failing to meet both the disease duration and frequency criteria (Group C). They completed a questionnaire survey regarding gastrointestinal symptoms (GSRS), QOL and psychological factors, which were compared among three groups. The total GSRS score was significantly higher in FD patients than non-FD patients (p = 0.012), which was higher than the healthy subjects (p < 0.0001). Furthermore, the total GSRS score of FD patients was comparable to that of Group A (p = 0.885), which was significantly higher than that of the Group B and C (p = 0.028, p = 0.014, respectively). HR-QOL is more impaired in FD patients than non-FD patients, which was significantly lower than the healthy subjects. That GSRS score in FD and Group A was comparable suggesting that an increased frequency of symptoms may have impact on the impairment of patient’s QOL.
- Published
- 2022
29. Mind the Gap: The Realities of Novel Irritable Bowel Syndrome Drug Access in Asian Clinical Practice.
- Author
-
Yong Sung Kim, Tadayuki Oshima, Siah, Kewin T. H., and Suck Chei Choi
- Subjects
- *
IRRITABLE colon , *TRANSIENT ischemic attack , *DRUG accessibility , *MEDICAL sciences - Abstract
This article explores the challenges of accessing novel drugs for irritable bowel syndrome (IBS) in Asian clinical practice. It emphasizes the importance of developing and implementing new IBS drugs that consider the unique characteristics of each region. However, selecting appropriate drugs is difficult due to the complex nature of IBS. The article also discusses the limited availability of novel IBS drugs in Asian countries, which can be attributed to high prices and lack of specific indications. It provides information on the availability of recommended drugs for IBS-C and IBS-D in various Asian countries, including Eluxadoline, Rifaximin, Alosetron, and Ramosetron. The text highlights the need for collaboration between patient advocacy groups, policymakers, and pharmaceutical companies to address the healthcare needs of Asian populations with IBS. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
30. Eosinophil-associated microinflammation in the gastroduodenal tract contributes to gastric hypersensitivity in a rat model of early-life adversity
- Author
-
Tomoaki Kono, Hiroto Miwa, Yoko Kogure, Katsuyuki Tozawa, Tadayuki Oshima, Masashi Fukushima, Satoshi Yamamoto, Hirokazu Fukui, Nobuko Imamura, Hirosato Kanda, Takashi Kondo, Toshihiko Tomita, Shenglan Wang, Yanjing Yang, Tadahiro Fujimura, Yi Dai, Koichi Noguchi, and Shaoqi Duan
- Subjects
0301 basic medicine ,Duodenum ,Physiology ,Rat model ,Rats, Sprague-Dawley ,03 medical and health sciences ,0302 clinical medicine ,Stress, Physiological ,Physiology (medical) ,Hypersensitivity ,Pressure ,Animals ,Medicine ,Inflammation ,Hepatology ,business.industry ,Maternal Deprivation ,Stomach ,Gastroenterology ,Eosinophil ,Early life ,Rats ,Eosinophils ,030104 developmental biology ,medicine.anatomical_structure ,Animals, Newborn ,Gastric Mucosa ,Gastritis ,Immunology ,030211 gastroenterology & hepatology ,business - Abstract
Gastric hypersensitivity is a major pathophysiological feature of functional dyspepsia (FD). Recent clinical studies have shown that a large number of patients with FD present with gastroduodenal microinflammation, which may be involved in the pathophysiology of FD. However, no animal model reflecting this clinical characteristic has been established. The underlying mechanism between microinflammation and FD remains unknown. In this study, using a maternal separation (MS)-induced FD model, we aimed to reproduce the gastroduodenal microinflammation and reveal the interaction between gastroduodenal microinflammation and gastric hypersensitivity. The MS model was established by separating newborn Sprague-Dawley rats for 2 h a day from
- Published
- 2021
- Full Text
- View/download PDF
31. Knowledge, Attitude, and Practice Survey of Gastroparesis in Asia by Asian Neurogastroenterology and Motility Association
- Author
-
Yong Sung Kim, Hiroto Miwa, Kewin Tien Ho Siah, Mahmudur Rahman, Liu Jin-song, Tanisa Patcharatrakul, Chien-Lin Chen, Tadayuki Oshima, Yinglian Xiao, Ching Liang Lu, Xiaohua Hou, Ari Fahrial Syam, Min Hu Chen, Hyojin Park, Andrew Seng Boon Chua, Sanjiv Mahadeva, and Duc Trong Quach
- Subjects
medicine.medical_specialty ,Asia ,Gastroparesis ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Dyspepsia ,China ,Gastric emptying ,business.industry ,Gastroenterology ,Diagnostic test ,Health care surveys ,Neurogastroenterology ,medicine.disease ,Health education ,030220 oncology & carcinogenesis ,Family medicine ,Treatment study ,Normative ,Original Article ,030211 gastroenterology & hepatology ,Neurology (clinical) ,business - Abstract
Background/Aims Gastroparesis is identified as a subject that is understudied in Asia. The scientific committee of the Asian Neurogastroenterology and Motility Association performed a Knowledge, Attitude, and Practices survey on gastroparesis among doctors in Asia. Methods The questionnaire was created and developed through a literature review of current gastroparesis works of literature by the scientific committee of Asian Neurogastroenterology and Motility Association. Results A total of 490 doctors from across Asia (including Bangladesh, China, Hong Kong, Indonesia, Japan, Malaysia, Myanmar, the Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam) participated in the survey. Gastroparesis is a significant gastrointestinal condition. However, a substantial proportion of respondents was unable to give the correct definition and accurate diagnostic test. The main reason for lack of interest in diagnosing gastroparesis was “the lack of reliable diagnostic tests” (46.8%) or “a lack of effective treatment” (41.5%). Only 41.7% of respondents had access to gastric emptying scintigraphy. Most doctors had never diagnosed gastroparesis at all (25.2%) or diagnosed fewer than 5 patients a year (52.1%). Conclusions Gastroparesis can be challenging to diagnose due to the lack of instrument, standardized method, and paucity of research data on normative value, risk factors, and treatment studies in Asian patients. Future strategies should concentrate on how to disseminate the latest knowledge of gastroparesis in Asia. In particular, there is an urgent need to estimate the magnitude of the problems in high risk and idiopathic patients as well as a standardized diagnostic procedure in Asia. (J Neurogastroenterol Motil 2021;27:46-54)
- Published
- 2021
- Full Text
- View/download PDF
32. Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis
- Author
-
Tadayuki Oshima, Ataru Igarashi, Hiroya Nakano, Hisato Deguchi, Ikuo Fujimori, and Jovelle Fernandez
- Subjects
Adult ,Sulfonamides ,Network Meta-Analysis ,Gastroenterology ,Bayes Theorem ,Proton Pump Inhibitors ,Treatment Outcome ,Heartburn ,Rabeprazole ,Gastroesophageal Reflux ,Esophagitis ,Humans ,Pyrroles ,Randomized Controlled Trials as Topic - Abstract
This systematic review and network meta-analysis aimed to assess the relative efficacy of vonoprazan and proton pump inhibitors (PPIs) on early heartburn symptom resolution in patients with erosive esophagitis.Limited available data directly compare the efficacy of vonoprazan, a first-in-class potassium-competitive acid blocker, with PPIs in erosive esophagitis.We conducted a systematic literature review (in MEDLINE and CENTRAL) and subsequent network meta-analysis according to Cochrane and PRISMA guidelines. Double-blind, randomized controlled trials in adults with erosive esophagitis treated with vonoprazan or a PPI were included in the analysis. Primary outcomes were heartburn symptom resolution rate on Day 1 and Day 7. The study was performed with all available data, using a random effects model within a Bayesian framework.Overall, 10 randomized controlled trials were included in the network meta-analysis. For heartburn resolution rate on Day 1 (9 of 10 trials), vonoprazan 20 mg once daily (QD) was superior to placebo (median odds ratio=16.75, 95% credible interval: 2.16-207.80). Point estimates numerically favored vonoprazan 20 mg QD over other comparators. For heartburn resolution rate on Day 7 (10 of 10 trials), vonoprazan 20 mg QD was superior to placebo and other comparators except rabeprazole 20 mg QD. Point estimates numerically favored vonoprazan 20 mg QD over rabeprazole 20 mg QD.In this study, vonoprazan 20 mg QD was equally effective in heartburn resolution on Day 1, and equally or more effective on Day 7 versus PPIs in adults with erosive esophagitis.
- Published
- 2022
33. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial
- Author
-
Toshihiko Tomita, Hirokazu Fukui, Tadayuki Oshima, Daisuke Morishita, Hiroto Miwa, Takeshi Kimura, and Sumire Mori
- Subjects
Adult ,Male ,Sennosides ,medicine.medical_specialty ,Constipation ,Senna ,medicine.medical_treatment ,Laxative ,Placebo-controlled study ,Placebo ,Gastroenterology ,law.invention ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Aged ,Chronic constipation ,Hepatology ,biology ,business.industry ,digestive, oral, and skin physiology ,Middle Aged ,biology.organism_classification ,Treatment Outcome ,Laxatives ,030220 oncology & carcinogenesis ,Chronic Disease ,Quality of Life ,Defecation ,Female ,030211 gastroenterology & hepatology ,medicine.symptom ,Magnesium Oxide ,business - Abstract
INTRODUCTION This is the first prospective, double-blinded, randomized, placebo-controlled trial to evaluate the safety and efficacy of a stimulant laxative compared with an osmotic agent for the treatment of chronic idiopathic constipation. METHODS Patients were randomly administered stimulant laxative (senna, 1.0 g), osmotic agent (magnesium oxide [MgO], 1.5 g), or placebo for 28 consecutive days. The primary endpoint was overall symptom improvement. Secondary endpoints were spontaneous bowel movement (SBM), complete SBM, and patient assessment of constipation quality of life (QOL). RESULTS Ninety patients (mean age, 42 years; 93% women; mean duration of symptoms, 9.9 years) were enrolled; all completed the study. The response rate for overall improvement was 11.7% in the placebo group, 69.2% in the senna group, and 68.3% in the MgO group (P < 0.0001). Change in SBM was significantly greater in the senna and MgO groups than that in the placebo group (P < 0.001). Similarly, change in complete SBM was significantly greater in the senna and MgO groups than that in the placebo group (P < 0.01). On the patient assessment of constipation QOL, significant improvements were seen in the senna and MgO groups compared with those in the placebo group (senna, P < 0.05; MgO, P < 0.001). The frequency of severe treatment-related adverse events was 0%. DISCUSSION Senna and MgO significantly improved the frequency of bowel movements and QOL score and seem to be effective in the treatment of constipation.
- Published
- 2020
- Full Text
- View/download PDF
34. Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome
- Author
-
Hiroto Miwa, Tadayuki Oshima, Tomoki Horikawa, Ko Miura, Mayumi Yamada, Chiyomi Ito, Toshihiko Tomita, and Hirokazu Fukui
- Subjects
Male ,medicine.medical_specialty ,TRPV6 ,Duodenum ,medicine.drug_class ,Gene Expression ,Receptors, Cytoplasmic and Nuclear ,digestive system ,Calcitriol receptor ,Receptors, G-Protein-Coupled ,Irritable Bowel Syndrome ,Internal medicine ,medicine ,Humans ,Mast Cells ,Receptor ,Irritable bowel syndrome ,Hepatology ,Bile acid ,business.industry ,digestive, oral, and skin physiology ,Gastroenterology ,medicine.disease ,G protein-coupled bile acid receptor ,Endocrinology ,medicine.anatomical_structure ,Receptors, Calcitriol ,Female ,Farnesoid X receptor ,business - Abstract
Background and aim Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, and bile acids are thought to be associated with the pathogenesis of IBS. Bile acid receptors are expressed on intestinal epithelial cells. However, no study has assessed bile acid receptor proteins in IBS. Therefore, we examined the intestinal mucosal expression of bile acid receptors in patients with IBS. Methods Intestinal biopsies were performed in patients with IBS and controls. Mast cells, vitamin D receptor (VDR), and somatostatin were stained with specific antibodies. Levels of VDR, farnesoid X receptor (FXR), takeda-G-protein-receptor-5 (TGR5), claudins, and transient-receptor-potential-cation-channel-subfamily-V-member 6 (TRPV6) were assessed by western blotting. Results 3Mast cell counts in the second part of the duodenum were significantly higher in patients with IBS than in controls. VDR protein levels were significantly elevated in the duodenum and terminal ileum of patients with IBS compared with controls, although this difference was not seen in the cecum or rectum. FXR and TGR5 protein levels did not differ in any part of the intestine. VDR-positive cryptal epithelia in IBS were distributed not only at basal crypt but also along the upper part of the basal crypt epithelial cells. In contrast, the pattern of gut somatostatin-positive cells, claudins, and TRPV6 levels did not differ. Conclusions The number of mast cells in the duodenum was significantly increased, and the protein expression levels of VDR, but not those of FXR or TGR5, were elevated in the duodenal epithelial crypt in patients with IBS.
- Published
- 2020
- Full Text
- View/download PDF
35. A Case of Severe Acute Gastritis as an Immune-Related Adverse Event After Nivolumab Treatment: Endoscopic and Pathological Findings in Nivolumab-Related Gastritis
- Author
-
Seiichi Hirota, Hiroto Miwa, Tadayuki Oshima, Takashi Kondo, Toshihiko Tomita, Hirokazu Fukui, Ikuo Matsuda, Ken Hara, Akio Tamura, Nobuhiko Ebisutani, Kumiko Nakamura, Tomonori Terada, and Katsuyuki Tozawa
- Subjects
Male ,medicine.medical_specialty ,Physiology ,Anti-Inflammatory Agents ,MEDLINE ,Gastroenterology ,Endoscopy, Gastrointestinal ,Immune system ,Internal medicine ,medicine ,Humans ,Adverse effect ,Immune Checkpoint Inhibitors ,Pathological ,Acute Gastritis ,business.industry ,Middle Aged ,Hepatology ,Nivolumab ,Gastritis ,Prednisone ,medicine.symptom ,business - Published
- 2020
- Full Text
- View/download PDF
36. The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements)
- Author
-
Sanjiv Mahadeva, Ping-Huei Tseng, Uday C Ghoshal, Alex Yu Sen Soh, Omesh Goyal, Junxiong Pang, Sanjeev Sachdeva, Jung Ho Park, Tanisa Patcharatrakul, Yinglian Xiao, Yu Kyung Cho, Yeong Yeh Lee, Justin C Y Wu, Kewin Tien Ho Siah, Andrew Ming Liang Ong, Tadayuki Oshima, Kee Wook Jung, M Masudur Rahman, Yen-Po Wang, Christopher K C Lai, and Hiroto Miwa
- Subjects
medicine.medical_specialty ,Esophageal motility disorders ,Motility ,Infection control ,Review ,03 medical and health sciences ,0302 clinical medicine ,Health care ,Pandemic ,medicine ,Intensive care medicine ,Gastrointestinal diseases ,Gastrointestinal motility ,business.industry ,Gastroenterology ,COVID-19 ,Guideline ,Neurogastroenterology ,medicine.disease ,Esophageal motility disorder ,Infectious disease (medical specialty) ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Neurology (clinical) ,business - Abstract
During the Coronavirus Disease 2019 (COVID-19) pandemic, practices of gastrointestinal procedures within the digestive tract require special precautions due to the risk of contraction of severe acute respiratoy syndrome coronavirus-2 (SARS-CoV-2) infection. Many procedures in the gastrointestinal motility laboratory may be considered moderate to high-risk for viral transmission. Healthcare staff working in gastrointestinal motility laboratories are frequently exposed to splashes, air droplets, mucus, or saliva during the procedures. Moreover, some are aerosol-generating and thus have a high risk of viral transmission. There are multiple guidelines on the practices of gastrointestinal endoscopy during this pandemic. However, such guidelines are still lacking and urgently needed for the practice of gastrointestinal motility laboratories. Hence, the Asian Neurogastroenterology and Motility Association had organized a group of gastrointestinal motility experts and infectious disease specialists to produce a position statement paper based-on current available evidence and consensus opinion with aims to provide a clear guidance on the practices of gastrointestinal motility laboratories during the COVID-19 pandemic. This guideline covers a wide range of topics on gastrointestinal motility activities from scheduling a motility test, the precautions at different steps of the procedure to disinfection for the safety and well-being of the patients and the healthcare workers. These practices may vary in different countries depending on the stages of the pandemic, local or institutional policy, and the availability of healthcare resources. This guideline is useful when the transmission rate of SARS-CoV-2 is high. It may change rapidly depending on the situation of the epidemic and when new evidence becomes available.
- Published
- 2020
37. 2019 Seoul Consensus on Esophageal Achalasia Guidelines
- Author
-
Hyun Chul Lim, Sung Eun Kim, Chan Hyuk Park, Andrew Seng Boon Chua, Tae Hee Lee, Hiroto Miwa, Uday C Ghoshal, Hee Seok Moon, Chul-Hyun Lim, Su Jin Hong, Jung Ho Park, Tadayuki Oshima, Moo In Park, Joong Goo Kwon, Tanisa Patcharatrakul, Do Hoon Kim, Suck Chei Choi, Shinwa Tanaka, Da Hyun Jung, Oh Young Lee, Kewin Tien Ho Siah, Yu Kyung Cho, Yang Won Min, Jong Kyu Park, Kyung Sik Park, Hidekazu Suzuki, Kwang Jae Lee, Kee Wook Jung, John E. Pandolfino, Minhu Chen, Hyojin Park, Justin C.Y. Wu, Hye Kyung Jung, Sanjiv Mahadeva, and Kyoungwon Jung
- Subjects
Myotomy ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,General surgery ,Gastroenterology ,Achalasia ,Guideline ,Neurogastroenterology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Esophageal motility disorder ,030220 oncology & carcinogenesis ,Epidemiology ,otorhinolaryngologic diseases ,medicine ,Esophageal sphincter ,Upper gastrointestinal ,030211 gastroenterology & hepatology ,Neurology (clinical) ,business - Abstract
Esophageal achalasia is a primary motility disorder characterized by insufficient lower esophageal sphincter relaxation and loss of esophageal peristalsis. Achalasia is a chronic disease that causes progressive irreversible loss of esophageal motor function. The recent development of high-resolution manometry has facilitated the diagnosis of achalasia, and determining the achalasia subtypes based on high-resolution manometry can be important when deciding on treatment methods. Peroral endoscopic myotomy is less invasive than surgery with comparable efficacy. The present guidelines (the "2019 Seoul Consensus on Esophageal Achalasia Guidelines") were developed based on evidence-based medicine; the Asian Neurogastroenterology and Motility Association and Korean Society of Neurogastroenterology and Motility served as the operating and development committees, respectively. The development of the guidelines began in June 2018, and a draft consensus based on the Delphi process was achieved in April 2019. The guidelines consist of 18 recommendations: 2 pertaining to the definition and epidemiology of achalasia, 6 pertaining to diagnoses, and 10 pertaining to treatments. The endoscopic treatment section is based on the latest evidence from meta-analyses. Clinicians (including gastroenterologists, upper gastrointestinal tract surgeons, general physicians, nurses, and other hospital workers) and patients could use these guidelines to make an informed decision on the management of achalasia.
- Published
- 2020
- Full Text
- View/download PDF
38. Correction to: Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis
- Author
-
Tadayuki Oshima, Liping Wu, Min Li, Hirokazu Fukui, Jiro Watari, and Hiroto Miwa
- Subjects
Gastroenterology - Published
- 2020
- Full Text
- View/download PDF
39. Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability
- Author
-
Toshihiko Tomita, Hirokazu Fukui, Daisuke Morishita, Ayako Maeda, Yutaka Makizaki, Yoshiki Tanaka, Hiroshi Ohno, Tadayuki Oshima, and Hiroto Miwa
- Subjects
Gastroenterology ,Neurology (clinical) - Abstract
Diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms frequently occur in patients with quiescent Crohn's disease (CD). To investigate the factors underlying IBS-D-like symptoms in patients with quiescent CD, we performed a comprehensive analysis of the clinical features and intestinal environment in those patients.We performed a prospective observational study of 27 patients with quiescent CD (CD activity index [CDAI] ≤ 150; C-reactive protein ≤ 0.3 mg/dL). The presence and severity of IBS-D-like symptoms, health-related quality of life, disease-specific quality of life, and status of depression and anxiety were evaluated. The level of intestinal permeability, fecal calprotectin and organic acids and the profiles of gut microbiome were analyzed.Twelve of the 27 patients with quiescent CD (44.4%) had IBS-like symptoms, and these patients showed a significantly higher CDAI, IBS severity index and anxiety score than those without. The inflammatory bowel disease questionnaire score was significantly lower in the patients with IBS-D-like symptoms. There were no significant differences in small intestinal/colonic permeability or the levels of organic acids between the patients with and without IBS-D-like symptoms. Fusicatenibacter was significantly less abundant in the patients with IBS-D-like symptoms whereas their fecal calprotectin level was significantly higher (384.8 ± 310.6 mg/kg) than in patients without (161.0 ± 251.0 mg/kg). The receiver operating characteristic curve constructed to predict IBS-D-like symptoms in patients with quiescent CD using the fecal calprotectin level (cutoff, 125 mg/kg) showed a sensitivity and specificity of 73.3% and 91.7%, respectively.Minimal inflammation is closely associated with the development of IBS-D-like symptoms in patients with quiescent CD.
- Published
- 2022
40. Epidemiology and Clinical Characteristics Based on the Rome III and IV Criteria of Japanese Patients with Functional Dyspepsia
- Author
-
Sota Aono, Toshihiko Tomita, Katsuyuki Tozawa, Daisuke Morishita, Keisuke Nakai, Takuya Okugawa, Masashi Fukushima, Tadayuki Oshima, Hirokazu Fukui, and Hiroto Miwa
- Subjects
functional dyspepsia ,Rome criteria ,epigastric symptoms ,digestive, oral, and skin physiology ,population characteristics ,General Medicine ,behavioral disciplines and activities ,digestive system diseases ,humanities - Abstract
The subtypes of functional dyspepsia (FD) differ depending on whether the Rome III criteria or the Rome IV criteria are used. We investigated the ability to diagnose FD patients using the Rome III and IV criteria. The subtypes of FD were evaluated using the Rome questionnaire. The Gastrointestinal Symptom Rating Score, health-related quality of life (HR-QOL; SF-8), and psychological scores (HADS, STAI) were evaluated. The questionnaire was collected from a total of 205 patients, and 54.1% were FD patients. The ratio of FD patients under the Rome III criteria was 19% for epigastric pain syndrome (EPS), 38% for postprandial distress syndrome (PDS), and 43% for an overlap of EPS and PDS, but under the Rome IV criteria overlap decreased to 17% and PDS increased to 64%. Patients whose subtype changed from overlap under the Rome III criteria to PDS under the Rome IV criteria were compared with PDS patients whose subtype did not change between the Rome III and IV criteria. The comparison showed that the former had significantly lower early satiation rates and significantly higher acid reflux and abdominal pain scores, demonstrating that EPS symptoms due to acid reflux after meals were clearly present. As a result of changing from the Rome III criteria to the Rome IV criteria, the number of overlap patients decreased, and the number of PDS patients increased.
- Published
- 2022
41. Duodenal cholinergic tuft cell number is increased in functional dyspepsia
- Author
-
Xinyi Huang, Tadayuki Oshima, Yasutada Akiba, Takanori Yoshimoto, Junji Chen, Masato Taki, Toshihiko Tomita, Hirokazu Fukui, Jonathan D. Kaunitz, and Hiroto Miwa
- Subjects
Endocrine and Autonomic Systems ,Physiology ,Duodenum ,Gastroenterology ,Cholinergic Agents ,Intracellular Signaling Peptides and Proteins ,Cell Count ,Protein Serine-Threonine Kinases ,Choline O-Acetyltransferase ,Doublecortin-Like Kinases ,Humans ,RNA, Messenger ,Dyspepsia ,Biomarkers - Abstract
Low-grade duodenal inflammation has recently been identified in patients with functional dyspepsia (FD). Chemosensory tuft cells were reported to be associated with gastrointestinal diseases. We therefore assessed duodenal tuft cell density and microinflammation in patients with FD to determine whether these measures could serve as useful biomarkers, and also correlated tuft cell density and microinflammation in FD patients.Duodenal biopsy specimens were obtained from patients with FD and from controls. Tuft cells, eosinophils, and mast cells were immunochemically stained with specific antibodies. Tuft cells were identified by immunostaining for doublecortin-like kinase 1 (DCLK1); cholinergic tuft cells were assessed by double staining for choline acetyltransferase (ChAT) and DCLK1. Immune-type tuft cells were assessed by IL-25 mRNA expression using real-time PCR.The density of intramucosal eosinophils and mast cells was significantly higher in the duodenum of FD patients than in controls. The density of tuft cells was significantly higher in the duodenum of FD patients compared with controls, and significantly correlated with eosinophil density in the duodenum of FD patients and controls. Moreover, a fraction of ChAT-positive cells was DCLK1 positive; all duodenal DCLK1+ tuft cells were ChAT-immunoreactive in FD and in control subjects.Cholinergic tuft cell density was higher in the duodenum of patients with FD and significantly correlated with eosinophil density. Further studies are needed to investigate the pathophysiological significance of tuft cells in FD and may provide valuable clues to the pathophysiology of FD.
- Published
- 2022
42. Gastric Xanthoma Is Related to the Rapid Growth of Gastric Cancer
- Author
-
Ko Miura, Tadayuki Oshima, Akio Tamura, Ken Hara, Takuya Okugawa, Masashi Fukushima, Toshihiko Tomita, Hirokazu Fukui, and Hiroto Miwa
- Subjects
gastric cancer ,growth ,xanthomatosis ,Medicine ,General Medicine ,Article - Abstract
Early detection of gastric cancer is important. However, rapid growth of gastric cancers that cannot be resected endoscopically occurs even with periodic check-ups. Accordingly, we assessed factors associated with the speed of gastric cancer growth by examining historical endoscopic images. A total of 1996 gastric cancer cases were screened, and characteristics of lesions with slow and rapid growth were assessed. A total of 114 lesions from 114 patients were included in the assessment. Sixty slow-growing and fifty-four rapidly growing gastric cancers were compared. Female sex and incidence of lesions in the lower part of the stomach were significantly less frequent in the rapid-growth group than in the slow-growth group. History of endoscopic treatment tended to be more frequent in the rapid-growth group. Age, body mass index, histology, Helicobacter pylori status, and medications did not differ significantly between groups. Xanthoma was significantly related to rapid growth of gastric cancer, and map-like redness tended to be more frequent in the rapid-growth group in univariate analysis. Xanthoma was significantly related to rapid growth of gastric cancer on multivariate analysis. Further studies are warranted to clarify the pathophysiological mechanisms involved in the speed of gastric cancer growth.
- Published
- 2021
- Full Text
- View/download PDF
43. Gastric Xanthelasma, Microsatellite Instability and Methylation of Tumor Suppressor Genes in the Gastric Mucosa: Correlation and Comparison as a Predictive Marker for the Development of Synchronous/Metachronous Gastric Cancer
- Author
-
Masashi Fukushima, Hirokazu Fukui, Jiro Watari, Chiyomi Ito, Ken Hara, Hirotsugu Eda, Toshihiko Tomita, Tadayuki Oshima, and Hiroto Miwa
- Subjects
genetic alteration ,endoscopic submucosal dissection ,predicting marker ,Medicine ,General Medicine ,gastric xanthelasma ,synchronous/metachronous gastric cancer ,neoplasms ,digestive system diseases ,Article - Abstract
A predictive marker for the development of synchronous/metachronous gastric cancer (GC) would be highly desirable in order to establish an effective strategy for endoscopic surveillance. Herein, we examine the significance of gastric xanthelasma (GX) and molecular abnormalities for the prediction of synchronous/metachronous GC. Patients (n = 115) were followed up (range, 12–122; median, 55 months) in whom the presence of GX and molecular alterations, including microsatellite instability (MSI) and methylation of human mutL homolog 1 (hMLH1), cyclin-dependent kinase inhibitor 2A (CDKN2A) and adenomatous polyposis coli (APC) genes, had been confirmed in non-neoplastic gastric mucosa when undergoing endoscopic submucosal dissection (ESD) for early GC. At the start of surveillance, the numbers of positive subjects were as follows: GX, 59 (51.3%); MSI, 48 (41.7%); hMLH1, 37 (32.2%); CDKN2A, 7 (6.1%); APC, 18 (15.7%). After ESD treatment, synchronous/metachronous GCs occurred in patients with the following positive factors: GX, 16 (27.1%); MSI, 7 (14.6%); hMLH1, 6 (16.2%); CDKN2A, 3 (42.9%); APC, 3 (16.7%). The presence of GX had no significant relationship to positivity for MSI or methylation of hMLH1, CDKN2A or APC. GX was significantly (p = 0.0059) and independently (hazard ratio, 3.275; 95% confidence interval, 1.134–9.346) predictive for the development of synchronous/metachronous GC, whereas those genetic alterations were not predictive. GX is a simple and powerful marker for predicting the development of synchronous or metachronous GC.
- Published
- 2021
44. Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.
- Author
-
Toshihiko Tomita, Hirokazu Fukui, Daisuke Morishita, Ayako Maeda, Yutaka Makizaki, Yoshiki Tanaka, Hiroshi Ohno, Tadayuki Oshima, and Hiroto Miwa
- Subjects
IRRITABLE colon ,CROHN'S disease ,GUT microbiome ,ORGANIC acids ,INFLAMMATORY bowel diseases ,RECEIVER operating characteristic curves - Abstract
Background/Aims Diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms frequently occur in patients with quiescent Crohn's disease (CD). To investigate the factors underlying IBS-D-like symptoms in patients with quiescent CD, we performed a comprehensive analysis of the clinical features and intestinal environment in those patients. Methods We performed a prospective observational study of 27 patients with quiescent CD (CD activity index [CDAI] ≤ 150; C-reactive protein ≤ 0.3 mg/dL). The presence and severity of IBS-D-like symptoms, health-related quality of life, disease-specific quality of life, and status of depression and anxiety were evaluated. The level of intestinal permeability, fecal calprotectin and organic acids and the profiles of gut microbiome were analyzed. Results Twelve of the 27 patients with quiescent CD (44.4%) had IBS-like symptoms, and these patients showed a significantly higher CDAI, IBS severity index and anxiety score than those without. The inflammatory bowel disease questionnaire score was significantly lower in the patients with IBS-D-like symptoms. There were no significant differences in small intestinal/colonic permeability or the levels of organic acids between the patients with and without IBS-D-like symptoms. Fusicatenibacter was significantly less abundant in the patients with IBS-D-like symptoms whereas their fecal calprotectin level was significantly higher (384.8 ± 310.6 mg/kg) than in patients without (161.0 ± 251.0 mg/kg). The receiver operating characteristic curve constructed to predict IBS-D-like symptoms in patients with quiescent CD using the fecal calprotectin level (cutoff, 125 mg/kg) showed a sensitivity and specificity of 73.3% and 91.7%, respectively. Conclusion Minimal inflammation is closely associated with the development of IBS-D-like symptoms in patients with quiescent CD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Author
-
Toshihiko Tomita, Hirokazu Fukui, Daisuke Morishita, Sumire Mori, Tadayuki Oshima, Shinichiro Shinzaki, and Hiroto Miwa
- Subjects
General Medicine ,ramosetron ,serotonin ,inflammatory bowel disease ,irritable bowel syndrome ,double-blind method - Abstract
Patients with quiescent inflammatory bowel disease (IBD) frequently suffer diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms, such as abdominal pain or stool irregularities. Here, we assessed the effect of ramosetron, a serotonin type 3 (5-HT3) receptor antagonist, on IBS-D-like symptoms in patients with quiescent IBD. Seventy patients with quiescent IBD, who met the Rome III diagnostic criteria for IBS-D, were randomly assigned to receive either ramosetron (5 μg; n = 35) or a placebo (n = 35) orally once daily for 4 weeks. The primary endpoint was the responder rate for global assessment of relief from overall IBS-D-like symptoms. The responder rates for relief of abdominal pain/discomfort and improvement of bowel habits were also evaluated. The responder rate for relief from overall IBS-D-like symptoms at the final evaluation point was significantly higher in the ramosetron group (35.5%) than in the placebo group (11.4%) (p = 0.037). The responder rate for improvement of bowel habits was significantly higher in the ramosetron group (38.7%) than in the placebo group (14.3%) (p = 0.028). The reduction of stool frequency was significantly greater in the ramosetron group than in the placebo group (p = 0.044). Ramosetron is effective for relief of overall IBS-D-like symptoms in patients with quiescent IBD.
- Published
- 2022
- Full Text
- View/download PDF
46. The Link between Type III Reg and STAT3-Associated Cytokines in Inflamed Colonic Tissues
- Author
-
Hiroshi Kiyama, Tadayuki Oshima, Xuan Wang, Hirokazu Fukui, Hiroto Miwa, Xin Xu, Ying Ran, Nobuhiko Ebisudani, Jiro Watari, Heihachiro Nishimura, Toshihiko Tomita, and Yoshihito Inoue
- Subjects
STAT3 Transcription Factor ,0301 basic medicine ,Article Subject ,Colon ,Immunology ,Pancreatitis-Associated Proteins ,chemical and pharmacologic phenomena ,Inflammation ,Biology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Western blot ,Gene expression ,lcsh:Pathology ,medicine ,Animals ,Humans ,Colitis ,STAT3 ,medicine.diagnostic_test ,Interleukin-6 ,Interleukins ,Dextran Sulfate ,Interleukin-17 ,hemic and immune systems ,Cell Biology ,HCT116 Cells ,medicine.disease ,Pathophysiology ,Mice, Inbred C57BL ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Cytokines ,Immunohistochemistry ,Phosphorylation ,Female ,Caco-2 Cells ,medicine.symptom ,Research Article ,lcsh:RB1-214 - Abstract
Reg (regenerating gene) family proteins are known to be overexpressed in gastrointestinal (GI) tissues under conditions of inflammation. However, the pathophysiological significance of Reg family protein overexpression and its regulation is still unclear. In the present study, we investigated the profile ofRegfamily gene expression in a colitis model and focused on the regulation of Reg IIIβand IIIγ, which are overexpressed in inflamed colonic mucosa. C57BL/6 mice were administered 2% dextran sulfate sodium (DSS) in drinking water for five days, and their colonic tissues were investigated histopathologically at interval for up to 12 weeks. Gene expression of theRegfamily and cytokines (IL-6,IL-17, andIL-22) was evaluated by real-time RT-PCR, and Reg IIIβ/γexpression was examined by immunohistochemistry. The effects of cytokines on STAT3 phosphorylation and HIP/PAP (type III REG) expression in Caco2 and HCT116 cells were examined by Western blot analysis. AmongRegfamily genes,Reg IIIβandIIIγwere alternatively overexpressed in the colonic tissues of mice with DSS-induced colitis. The expression of STAT3-associatedcytokines(IL-6,IL-17, andIL-22) was also significantly increased in those tissues, being significantly correlated with that ofReg IIIβ/γ. STAT3 phosphorylation and HIP/PAP expression were significantly enhanced in Caco2 cells upon stimulation with IL-6, IL-17, and IL-22. In HCT116 cells, those enhancements were also observed by IL-6 and IL-22 stimulations but not IL-17. The link between type III Reg and STAT3-associated cytokines appears to play a pivotal role in the pathophysiology of DSS-induced colitis.
- Published
- 2019
- Full Text
- View/download PDF
47. Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function
- Author
-
Tadayuki Oshima, Norio Nishii, Takashi Kondo, Tomoaki Kono, Hirotsugu Eda, Akio Tamura, Katsuyuki Tozawa, Min Li, Hirokazu Fukui, Hiroto Miwa, Takahisa Yamasaki, Toshihiko Tomita, Kumiko Nakamura, and Tomohiro Ogawa
- Subjects
Inflammation ,Pharmacology ,Occludin ,030226 pharmacology & pharmacy ,Interferon-gamma ,03 medical and health sciences ,chemistry.chemical_compound ,Lubiprostone ,0302 clinical medicine ,Claudin-1 ,medicine ,Humans ,Intestinal Mucosa ,Claudin ,Fluorescein isothiocyanate ,Barrier function ,Tight junction ,Chemistry ,General Medicine ,Chloride channel ,Caco-2 Cells ,medicine.symptom ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Introduction: Lubiprostone, a chloride channel activator, is said to reduce epithelial permeability. However, whether lubiprostone has a direct effect on the epithelial barrier function and how it modulates the intestinal barrier function remain unknown. Therefore, the effects of lubiprostone on intestinal barrier function were evaluated in vitro. Methods: Caco-2 cells were used to assess the intestinal barrier function. To examine the expression of claudins, immunoblotting was performed with specific antibodies. The effects of lubiprostone on cytokines (IFNγ, IL-6, and IL-1β) and aspirin-induced epithelial barrier disruption were assessed by transepithelial electrical resistance (TEER) and fluorescein isothiocyanate (FITC) labeled-dextran permeability. Results: IFNγ, IL-6, IL-1β, and aspirin significantly decreased TEER and increased epithelial permeability. Lubiprostone significantly improved the IFNγ-induced decrease in TEER in a dose-dependent manner. Lubiprostone significantly reduced the IFNγ-induced increase in FITC labeled-dextran permeability. The changes induced by IL-6, IL-1β, and aspirin were not affected by lubiprostone. The expression of claudin-1, but not claudin-3, claudin-4, occludin, and ZO-1 was significantly increased by lubiprostone. Conclusion: Lubiprostone significantly improved the IFNγ-induced decrease in TEER and increase in FITC labeled-dextran permeability. Lubiprostone increased the expression of claudin-1, and this increase may be related to the effect of lubiprostone on the epithelial barrier function.
- Published
- 2019
- Full Text
- View/download PDF
48. Glutamine Blocks Interleukin-13-Induced Intestinal Epithelial Barrier Dysfunction
- Author
-
Chiyomi Ito, Hirokazu Fukui, Hiroto Miwa, Tadayuki Oshima, Min Li, Toshihiko Tomita, and Mayumi Yamada
- Subjects
medicine.medical_specialty ,Glutamine ,Inflammatory bowel disease ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Claudin-1 ,medicine ,Humans ,LY294002 ,Intestinal Mucosa ,Fluorescein isothiocyanate ,Irritable bowel syndrome ,Interleukin-13 ,Tight junction ,Chemistry ,Akt/PKB signaling pathway ,Gastroenterology ,Epithelial Cells ,medicine.disease ,Endocrinology ,030220 oncology & carcinogenesis ,Interleukin 13 ,030211 gastroenterology & hepatology ,Caco-2 Cells - Abstract
Introduction: Impaired intestinal epithelial barrier function is a hallmark of a variety of pathological conditions such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). IBD patients with IBS-like symptoms show higher interleukin-13 (IL-13) serum levels and poor psychological well-being. Supplementary glutamine reduced the daily bowel movement frequency, improved the stool form, and normalized intestinal hyperpermeability. This study was aimed at assessing the effects of IL-13 and supplementary glutamine on human intestinal epithelial function in vitro. Methods: Caco-2 cells were grown on TranswellTM inserts. IL-13 was added to the basolateral compartment, and transepithelial electrical resistance (TEER) and fluorescein isothiocyanate (FITC) labeled-dextran permeability measured. Effects of glutamine or the phosphatidylinositol-3-kinase inhibitor LY294002 were assessed. Involvement of tight junction proteins was assessed using Western blotting and immunofluorescence staining. Results: IL-13 significantly decreased TEER and increased FITC labeled-dextran epithelial permeability. IL-13 stimulation decreased the claudin-1 expression and increased the claudin-2 expression. Glutamine alleviated IL-13-induced decrease of TEER and increase of FITC labeled-dextran permeability. Further, the phosphatidylinositol-3-kinase inhibitor showed this alleviating effect while the signal transducer and activator of transcription 6 inhibitor did not. Conclusions: IL-13 induced barrier integrity impairment by decreasing claudin-1 and increasing claudin-2. Glutamine alleviated IL-13-induced barrier dysfunction by increasing claudin-1 expression, via disruption of the phosphatidylinositol-3-kinase/Akt signaling pathway.
- Published
- 2019
- Full Text
- View/download PDF
49. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use
- Author
-
Tadakazu Shimoda, Toshihiko Tomita, Hirokazu Fukui, Hiroto Miwa, Kiron M. Das, Chiyomi Ito, Jiro Watari, and Tadayuki Oshima
- Subjects
Male ,Time Factors ,lcsh:Medicine ,Predictive markers ,Article ,Cohort Studies ,Cancer epigenetics ,Stomach Neoplasms ,Gastric mucosa ,Medicine ,Humans ,Gene Silencing ,lcsh:Science ,Aged ,Aspirin ,Multidisciplinary ,Predictive marker ,biology ,Helicobacter pylori ,Molecular medicine ,business.industry ,lcsh:R ,Intestinal metaplasia ,Cancer ,Methylation ,DNA Methylation ,Middle Aged ,medicine.disease ,biology.organism_classification ,MicroRNAs ,medicine.anatomical_structure ,Risk factors ,Gastric Mucosa ,DNA methylation ,Cancer research ,Female ,lcsh:Q ,business ,Gastric cancer ,Precancerous Conditions ,medicine.drug - Abstract
The risk of gastric cancer (GC) declines after Helicobacter pylori (H. pylori) eradication and long-term aspirin use. We evaluated the effects of H. pylori eradication (Cohort 1) and aspirin use (Cohort 2) on the methylation of microRNAs (miRNAs), such as miR-34c, miR-124a-3, miR-129-2, and miR-137, in the gastric mucosa with and without GC, i.e., in atrophic mucosal glands without intestinal metaplasia (non-IM) and intestinal metaplastic glands (IM). DNA was isolated from non-IM and IM separately using laser caption microdissection. In Cohort 1, H. pylori eradication was associated with a significant reduction of miR-124a-3 methylation only in non-IM, but not in IM. miR-129-2 methylation in non-IM may be a surrogate marker of GC in H. pylori-infected patients. In Cohort 2, aspirin did not reverse miRNA methylation in either non-IM or IM, irrespective of H. pylori infection. miR-129-2 methylation in non-IM was an independent predictive marker of GC in H. pylori-infected but not -eradicated patients. These results indicate that H. pylori eradication and aspirin use were less effective for improving methylation in IM than in non-IM; thus, these interventions are recommended at an early stage prior to the development of IM to prevent GC development. In addition, the effects of the interventions were not uniform for each miRNA gene.
- Published
- 2019
- Full Text
- View/download PDF
50. Chenodeoxycholic Acid Releases Proinflammatory Cytokines from Small Intestinal Epithelial Cells Through the Farnesoid X Receptor
- Author
-
Yoshitaka Kitayama, Takashi Kondo, Tadayuki Oshima, Katsuyuki Tozawa, Hirotsugu Eda, Kumiko Nakamura, Takahisa Yamasaki, Toshihiko Tomita, Hirokazu Fukui, Takuya Okugawa, Akio Tamura, Hiroto Miwa, Tomoaki Kono, Tomoki Horikawa, Min Li, Jiro Watari, and Tomohiro Ogawa
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.drug_class ,Biopsy ,Receptors, Cytoplasmic and Nuclear ,Chenodeoxycholic Acid ,Permeability ,Proinflammatory cytokine ,Irritable Bowel Syndrome ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Intestinal mucosa ,Ileum ,Pregnenediones ,Chenodeoxycholic acid ,Internal medicine ,medicine ,Humans ,RNA, Messenger ,Interleukin 8 ,Aged ,Bile acid ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Interleukin-8 ,Gastroenterology ,Middle Aged ,Healthy Volunteers ,Enterocytes ,Endocrinology ,chemistry ,Case-Control Studies ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,Tumor necrosis factor alpha ,Guggulsterone ,Farnesoid X receptor ,Caco-2 Cells - Abstract
Background/Aims: Bile acids have recently been associated with the pathogenesis of irritable bowel syndrome (IBS). We therefore evaluated the expression of bile acid receptors in the intestinal mucosa of IBS patients as well as the effects of bile acids on small intestinal epithelial cells. Methods: Intestinal biopsy specimens were obtained from 15 IBS patients and 15 healthy controls. The effects of bile acid stimulation on trans-epithelial electrical resistance (TEER) and permeability in differentiated Caco-2 cells were measured. Proinflammatory cytokines were measured by enzyme-linked immunosorbent assay. mRNA levels of bile acid receptors, including farnesoid X receptor (FXR), and cytokines were determined by real-time reverse transcription-PCR. Caco-2 cells were pre-incubated with the FXR antagonist guggulsterone. Results: FXR mRNA expression at the terminal ileum was increased in IBS patients. Chenodeoxycholic acid (CDCA) significantly decreased TEER, increased permeability, and increased interleukin-8 (IL-8) release from Caco-2 cells. Pre-incubation with guggulsterone blocked CDCA-mediated IL-8 release; however, the decrease in TEER was not reversed. CDCA-induced IL-6 and IL-8 mRNA levels were blocked by guggulsterone. CDCA increased IL-6, tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor release, whereas guggulsterone significantly blocked IL-6 and TNF-α release. Conclusions: FXR expression was elevated at the terminal ileum in IBS patients. CDCA increased proinflammatory cytokines, while guggulsterone blocked these increases.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.